Tuesday, March 09, 2021 3:48:35 PM
A (soon to be released) Canaccord Genuity report?
A possible agreement from the FDA for the Company to file for an EUA? (“the Company aims to approach the FDA to obtain agreement on filing an Emergency Use Authorization (“EUA”) for Bucillamine…”)
An expansion of the clinical sites from 14 to…?
Any other reasonable thoughts?
Also, how good does Michael Frank’s recently bought shares look now? And, if today’s action is indicative of pending (good) news from the Company then could Michael Frank’s open market purchase be perceived as buying on insider knowledge?
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM